Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0LOV stock hub

LON/0LOV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

315.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LOV

In the news

Latest news · LON/0LOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-786.2

P25 -54.2P50 2.1P75 13.7

ROIC-100.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	102
Employees Change	5%
Employees Change Percent	6.85
Enterprise value	$244.7M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US92337C2035
Last refreshed	2026-05-10
Market cap	$315.3M
Price	$4.99
Price currency	USD
Rev Per Employee	368,146.75x
Sector	Healthcare
Sic	2836
Symbol	lon/0LOV
Website	https://www.verastem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-46.58%
EV Earnings	-1.67x
EV/Sales	6.73x
P/B ratio	5.09x
P/S ratio	8.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	85.13%
Gross Profit	$32M
Gross Profit Growth	322.13%
Gross Profit Growth5 Y	-4.09%
Net Income	$-146.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-391.16%
Profit Per Employee	$-1.4M
ROA	-59.41
Roa5y	-47.85
ROCE	-106.1
ROE	-786.2
Roe5y	-465
ROIC	-100.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.51%
Cagr3y	-2.27%
Cagr5y	-31.78%
EPS Growth Quarters	2
EPS Growth Years	6
Revenue Growth	395.85x
Revenue Growth Years	1x
Revenue Growth5 Y	-10.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.28
Assets	$172.5M
Cash	$137.6M
Current Assets	$148.8M
Current Liabilities	$49M
Debt	$64.7M
Debt Equity	$1.05
Equity	$61.9M
Interest Coverage	-128.7
Liabilities	$110.6M
Long Term Assets	$23.7M
Long Term Liabilities	$61.6M
Net Cash	$72.9M
Net Cash By Market Cap	$23.1
Net Cash Growth	135.94%
Net Debt Equity	$-1.18
Tangible Book Value	$49.7M
Tangible Book Value Per Share	$0.57
WACC	5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.04
Net Working Capital	$-29.8M
Quick ratio	2.87
Working Capital	$103M
Working Capital Turnover	$0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-88.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.5%
200-day SMA	7.45
3Y total return	-6.65%
50-day SMA	5.73
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.22%
All Time High	85.92
All Time High Change	-94.2%
All Time High Date	2018-10-05
All Time Low	2.14
All Time Low Change	133.05%
All Time Low Date	2024-08-05
ATR	0.39
Beta	0.43
Ch YTD	-34.92
High	5.79
High52	11.17
High52 Date	2025-09-05
High52ch	-55.36%
Low	4.76
Low52	4.08
Low52 Date	2025-06-27
Low52ch	22.18%
Ma50ch	-13.03%
Price vs 200-day SMA	-33.11%
RSI	38.72
RSI Monthly	43.44
RSI Weekly	40.74
Sharpe ratio	-0.07x
Sortino ratio	-0.03
Total Return	-88.82%
Tr YTD	-34.92
Tr1m	-6.65%
Tr1w	-13.15%
Tr3m	-24.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-129.4M
Operating margin	-344.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75,004,772%
Net Borrowing	-1,070,930.4
Shares Insiders	0.59%
Shares Institutions	79.73%
Shares Qo Q	14.34%
Shares Yo Y	88.82%
Short Ratio	8.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,344.2x
Bv Per Share	0.71
Ch1m	-6.65
Ch1w	-13.15
Ch1y	-21.5
Ch3m	-24.81
Ch3y	-6.65
Ch5y	-85.22
Ch6m	-35.23
Change	-12.18%
Change From Open	-3.2
Close	5.68
Days Gap	-9.27
Depreciation Amortization	731,313.5
Dollar Volume	159,076.3
Earnings Date	2026-05-07
EBIT	$-129.4M
EBITDA	$-128.6M
EPS	$-1.83
F Score	2
Financing CF	170,067,984
Fiscal Year End	December
Founded	2,010
Investing CF	-19,416,543
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2023-06-01
Last Split Type	Reverse
Ma150	7.27
Ma150ch	-31.39%
Ma20	5.89
Ma20ch	-15.31%
Net CF	36,337,009
Next Earnings Date	2026-08-10
Open	5.15
Position In Range	22.22
Ppne	2,048,704.6
Price Date	2026-05-08
Ptbv Ratio	6.34
Relative Volume	5.03x
Revenue	37,550,968x
SBC By Revenue	19.49x
Share Based Comp	7,317,081
Tr6m	-35.22%
Volume	31,911
Z Score	-6.97

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LOV pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+79.7%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.7

Neutral momentum band

Price vs 200-day MA

-33.1%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LOV stock rating?

lon/0LOV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LOV analysis?

The full report lives at /stocks/lon/0LOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LOV?

The latest report frames lon/0LOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.